GADD45B and Hyperglycemia: The inhibition of liver adipogenesis and inflammation caused by TCPOBOP observed in wild‐type mice was largely eliminated in Gadd45β−/− mice, with CAR activation mitigating hyperglycaemia by hindering glucose production and bolstering hepatic glucose uptake [43].